However, the length of time a person stays on Semaglutide GLP-1 will depend on several factors, including their weight loss goals, individual response to treatment, and potential side effects
[11] [14] Urgent assessment is needed for hot flashes accompanied by systemic symptoms (fever, unexplained weight loss), abnormal vaginal bleeding, or atypical features suggesting alternative diagnoses
Association of change in muscle mass assessed by D(3) -creatine dilution with changes in grip strength and walking speed
Senior author Klara Klein, of UNC School of Medicine in the US, said that, while a prior clinical trial of an older GLP-1 drug for AUD was inconclusive, "as prescription of semaglutide and similar medications escalated, anecdotal reports of reduced alcohol use became very common." The team have called for large-scale trials to explore the potential of semaglutide and other GLP-1-acting drugs in AUD, which claims an estimated 178,000 deaths per year in the US, with relatively few people seeking treatment for the disorder
Some patients benefit from weekly injections, while others may only need them monthly